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Abstract: The Internet has played a major role in the distribution of New Psychoactive Substances
(NPS), and crypto markets are increasingly used for the anonymous sale of drugs, including NPS.
This study explores the availability of individual NPS and vendors on the crypto markets and
considers whether crypto markets are a reliable platform for the sale of NPS. Data was collected
from 22 crypto markets that were accessed through the hidden web using the Onion Router (Tor).
Data collection took place bimonthly from October 2015 to October 2016 as part of the CASSANDRA
(Computer Assisted Solutions for Studying the Availability aNd DistRibution of novel psychoActive
substances) project. In seven snapshots over 12 months, 808 unique vendors were found selling
256 unique NPS. The total number of individual NPS and vendors increased across the data collection
period (increase of 93.6% and 71.6%, respectively). Only 24% (n = 61) of the total number of NPS and
4% (n = 31) of vendors appeared in every snapshot over the 12 months, whereas 21% (n = 54) of NPS
and 45% (n = 365) of vendors only appeared once throughout the data collection. The individual
NPS and vendors did not remain the same over the 12 months. However, the availability of
NPS and vendors selling NPS grew. NPS consistently available on crypto markets could indicate
popular substances.
Keywords: new psychoactive substances; legal highs; darknet; hidden web; crypto market
1. Introduction
New psychoactive substances (NPS) are an emerging phenomenon, and their representation on
the hidden web (also known as the darknet) is under-researched. The Internet has played a major role
in the distribution of NPS, and drug marketplaces (also known as crypto markets) on the hidden web
are increasingly used for the anonymous sale of drugs, including NPS [1–3].
The European Union (EU) Early Warning System currently monitors over 650 substances [4].
However, not all substances are a cause of concern, and NPS rise and fall in popularity. Only a few
have had sizable prevalence or media attention [5], and research has shown that the legal status
of a substance is one of the factors determining why some NPS become popular and others do
not [6]. Various legislations have been created to tackle NPS diffusion across Europe and the world.
For example, the UK introduced the Psychoactive Substances Act in May 2016, which prohibited
the import, export, and supply of psychoactive substances (with some exemptions) but permitted
possession [7]. The Act achieved a reduction in UK-based online stores and offline retail stores [8].
As more countries seek to restrict access to NPS, the legal markets could be displaced by alternative
routes such as street-level drug dealing or crypto markets [3]. However, movement to the illicit market
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is dependent on its popularity, and therefore only those NPS with sufficient demand will transition
into it [9].
On the hidden web, drugs can be sold and purchased anonymously through crypto markets
that use an “eBay”-style system where buyers can publicly review the sellers and therefore build
their reputation, attracting future transactions [10–14]. Conversely, negative reviews can discourage
buyers and shun unworthy vendors from the crypto markets [11,15]. It is argued that this feedback
mechanism and creation of a reputation are vital to the continuing function of the market and also
represent an explanation for a vendor’s lifespan [15,16]. To date, the majority of crypto market research
has been conducted on the Silk Road [13,17–21], which was closed by law enforcement in 2013 [22].
Christin [20] found that most sellers disappeared before three months, and most items sold for less than
three weeks. Christin [20] proposed the theory that short vendor lifespans could be due to lack of stock
or to vendors using the “stealth mode”. The stealth mode consists in vendors removing their listings
or only selling their listings to a specific customer base [13]. Potentially, the turnover of vendors is a
product of the instability of the crypto markets; individual crypto markets are said to be unpredictable
and have a frequent turnover, causing instability in the community [23]. Law enforcements have
succeeded in closing crypto markets in the past [14,22,24]. However, all successful operations have not
stopped the online trade of drugs [25], and the number of vendors has increased [3]. Previous research
on crypto markets have shown a small yet definite presence of NPS. Barratt, Ferris, and Winstock [18]
examined the use of Silk Road in a sample from the UK, US, and Australia and found that out of the
top 20 substances that were purchased, four of these were NPS. In addition, Van Buskirk et al. [3]
explored crypto markets in 2015 and concluded that around one-fifth of vendors offered NPS.
Crypto markets are increasingly being used for the sale and purchase of drugs, regardless of the
instability both the markets and the vendors show. To date, research has not focussed specifically on
the lifespan of vendors selling NPS, substances whose popularity and availability are unpredictable.
This paper, therefore, aims to explore the lifespan of individual NPS sold on the crypto markets,
explore the lifespan of individual vendors selling NPS on the crypto markets, and consider whether
crypto markets are a reliable platform for the sale of NPS.
2. Methods
The study was part of the CASSANDRA (Computer Assisted Solutions for Studying the
Availability aNd DistRibution of novel psychoActive substances) project [26]. The crypto markets on
the hidden web were accessed through Tor (torproject.org, 501(c)(3), The Tor Project, Inc., Cambridge,
MA, USA), and the data were collected bimonthly over 12 months in October, December (2015),
February, April, June, August, and October (2016). The data were collected over two days in each of
the seven snapshots. The crypto markets that were included sold NPS, were conducted in English,
and had an open registration at the time of collection. The crypto markets present over the 12 months
of data collection fluctuated because of crypto markets opening, adding NPS to their sales, or closing
following exit scams or law enforcement. A table of the crypto markets included in this study can be
found elsewhere [27].
Data were collected on each crypto market for NPS being sold that was visible to the researchers.
The data collected were: name of the NPS (not including conventional illicit drugs, steroids, or prescription
drugs), name of the vendor selling NPS, and name of the crypto market used by the vendor. Some NPS
were sold under various aliases; these were categorised by their most common name. Furthermore,
branded NPS that were commonly found on the visible Internet were categorised according to their
contents. All analyses were performed using Microsoft Excel 2016 (Microsoft Office 2016, Microsoft,
Redmond, WA, United States), unless otherwise specified.
All users on crypto markets were anonymous. The research was purely observational and did not
involve interaction with either buyers or sellers. The study was approved by King’s College London
PNM Research Ethics reference number: LRS-15/16-3084 as part of the CASSANDRA project.
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3. Results
The total number of individual NPS and vendors increased across the seven snapshots in the data
collection period (increase of 93.6% and 71.6%, respectively) (Figure 1). Over 12 months, a total of
808 individual vendors were found selling 256 individual NPS.
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Figure 1. Number of NPS and vendors in each month of data collection (seven snapshots in 12 months).
NPS: New Psychoactive Substances.
A total corresponding to 21% (n = 54) of the NPS reported over the 12-month period only appeared
in one sna shot (Figure 2). Fourteen p rcent (n = 36) of the total numb r f NPS appeared in two of the
seven snapshots. Ten percent (n = 26) a peared in three of the seven snapshots, 7% (n = 18) appeared
in four of the seven s apshots, 11% (n = 29) appeared in five of the seven snapshots, a d 13% (n = 32)
appeared in six of the seven snapshots. In addition, 24% (n = 61) of the total number of NPS appeared
in each of the seven snapshots over the 12-month period (Table 1).
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New Psychoactive Substances.
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Table 1. New Psychoactive Substances that were available in every snapshot over 12 months of data collection (n = 61).
Benzodiazepine






























































para-fluoro-PV8) 2CE (Tripstacy) Salvia
4-MEC (4-methylethcathinone) 2CI (Tripstacy)
4-MMC (mephedrone, Mcat,
meowmeow, bubble, drone) 2CP (Tripstacy)










Dibutylone (bk-DMBDB, booty) 4FA (4-FMP, PAL-303,Flux, PFA)
Dimethocaine (DMC, larocaine) 5-EAPB (1-(benzofuran-5-yl)-N-ethylpropan-2-amine)
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Almost half of all vendors (45%, n = 365) appeared only once over the 12-month period (Figure 3).
Twenty-three percent (n = 184) of the total number of vendors appeared in two snapshots over the
12-month period, 13% (n = 103) appeared in three snapshots, 8% (n = 63) appeared in four snapshots,
4% (n = 30) appeared in five snapshots, 4% (n = 32) appeared in six snapshots, and only 4% (n = 31) of
the total number of vendors appeared in all seven snapshots.
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4. Discussion
The total umber of individual NPS and vendors increased over the 12-month duration of the
study. Almost half of the total number of vendors had a lifespan of only a few months, and the NPS
advertised fluctuated over the study. One-fifth of NPS were available for the entirety of the study,
whereas just under one-quarter were only available for a few months before disappearing. From the
results of this study, the contents of the NPS market on the crypto markets varied, but a market was
consistently available.
Research has shown that the use of crypto markets and the availability of substances including
NPS have increased in recent years [3,20,24]. The results from this study complement these findings as
the availability of NPS increased over the data collection period. The increased availability of NPS on
the crypto markets suggests that NPS are being purchased via this method and that crypto markets
are seen as a viable platform for the sale of NPS. This is necessary to observe because of the changing
legislations surrounding these substances in countries around the globe, such as the ban in the UK that
was implemented during this study [7]. Legal markets will look to migrate to other platforms.
This study found that 256 different NPS were available for purchase over the 12 months of the
study, and nearly one-quarter of NPS remained available on the crypto markets, suggesting that
these substances could be the most popular NPS. The majority of the NPS that were available in
every snapshot were cathinones and phenethylamines (categorised according to [5]). However, there
was frequent turnover throughout the study, whereby some NPS were available for purchase for
a few months and then disappeared from availability. This pattern may have mirrored changes in
popularity within the overall NPS market, fluctuating because of legality, ease of access, or similarities
to traditional drugs [4,9]. It is possible that certain NPS were removed from the market because limited
stocks were available to the vendors or because the demand of a specific NPS did not match up to its
availability. Another possibility is that the feedback from the customers about the NPS was negative,
and the stock was removed [15].
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Almost half of the vendors were only captured in one snapshot over the course of the data
collection, and the number of vendors who appeared in the data reduced as the snapshots increased
(Figure 3). These findings show that the lifespan of the vendors was relatively short, and just under half
of the vendors were available for under four months, mirroring what was found in the literature [20,28].
There are potential reasons for a short lifespan; research has suggested that vendors could only be
selling their limited stock, or that vendors move into stealth mode after they have gathered a sufficient
client base [13,20]. Furthermore, the crypto market system is built on trust and reputation; if vendors
do not build an adequate reputation, they may remove themselves from the market either indefinitely
or only apparently by setting up new accounts [15,28]. Only 4% of vendors remained available in every
snapshot over the 12 months of this study. Perhaps, these consistent vendors were highly reputable
vendors or vendors with a loyal customer base [28].
This study has several limitations. As this study was exploratory and lacked contact with the
vendors, we were unable to verify whether the substances advertised were the same substances being
purchased and received by the customers. Because of anonymity, another limitation is that studies like
the present one are unable to capture how many vendor profiles are controlled by one person or if the
number of vendors that are only available for a few months before disappearing are, in fact, opening
and closing various accounts [29].
5. Conclusions
Online sales hold a predominant portion of the NPS market, and crypto markets are an emerging
source of sale. NPS sold on crypto markets should be monitored to track the popularity and availability
of specific substances. Our study found that vendors selling NPS had short lifespans, with half of the
vendors only appearing once in the data collection. Individual NPS had longer lifespans, however
not all NPS were available over the study period; only a quarter of the total NPS were available in
all snapshots over the year. Regardless of the fluctuation of the vendors in the NPS market on the
crypto markets, the number of NPS and vendors selling NPS increased over the year. The NPS that
consistently appeared across the 12 months of data collection may suggest what substances are popular
with the consumers. Crypto markets are therefore to be monitored for the sale of NPS, especially in
light of the tightening regulations being applied in various countries.
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